Tag: BiDil

  • Race has become a prominent focus for human biotechnology. Despite often good intentions, genetic technologies are being applied in a manner that may provide new justification for thinking about racial difference and racial disparities in biological terms—as if social categories of race reflect natural or inherent group differences.

  • Race-Based Medicine: Déjà Vu All Over Again? Biopolitical Times: The weblog of the Center for Genetics and Society 2012-09-18 Osagie K. Obasogie, Associate Professor of Law University of California, San Francisco Also: Senior Fellow Center for Genetics and Society Race-based medicine has been one of the more contentious issues in pharmaceutical research and development over…

  • Slooooooow Sales for BiDil® Biopolitical Times: The weblog of the Center for Genetics and Society 2006-10-18 Osagie K. Obasogie, Associate Professor of Law University of California, San Francisco Also: Senior Fellow Center for Genetics and Society Today’s Wall Street Journal reports that sales for BiDil®—the first drug to receive FDAapproval to treat a specific race—are…

  • Personalizing Medicine: Beyond Race Virtual Mentor: American Medical Association Journal of Ethics Volume 14, Number 8 (August 2012) pages 628-634 Timothy Chang, MD-PhD Student University of Wisconsin, Madison McNearney TA, Hunnicutt SE, Fischbach M, et al. Perceived functioning has ethnic-specific associations in systemic sclerosis: another dimension of personalized medicine. J Rheumatol. 2009;36(12):2724-2732. Considering the explosion…

  • Race Finished: Book Review American Scientist April-May, 2012 Jan Sapp, Professor of Biology and History York University, Toronto Race?: Debunking a Scientific Myth. Ian Tattersall and Rob DeSalle. xviii + 226 pp. Texas A&M University Press, 2011. Race and the Genetic Revolution: Science, Myth, and Culture. Edited by Sheldon Krimsky and Kathleen Sloan. xiv +…

  • Race and the Genetic Revolution: Science, Myth, and Culture Columbia University Press September 2011 304 pages 1 illus; 4 tables Paper ISBN: 978-0-231-15697-4 Cloth ISBN: 978-0-231-15696-7 Edited by: Sheldon Krimsky, Professor of Urban & Environmental Policy & Planning; Adjunct Professor of Public Health and Family Medicine Tufts School of Medicine Tufts University, Medford, Massachusetts Kathleen…

  • Medicating Race: Heart Disease and Durable Preoccupations with Difference Massachusetts Institute of Technology 2007 250 pages Anne Pollock, Assistant Professor of Science, Technology and Culture Georgia Institute of Technology, Atlanta, Georgia Submitted to the Program in Science, Technology and Society In Partial Fulfillment of the Requirements of the Degree of Doctor of Philosophy in the…

  • “Racially-Tailored” Medicine Unraveled American University Law Review Volume 55, Number 2 (December 2005) pages 395-452 Sharona Hoffman, Professor of Law, Professor of Bioethics, and Associate Director of the Law-Medicine Center Case Western Reserve University School of Law Table of Contents Introduction I. “Race-Based” Research and Therapeutic Practices A. The Story of BiDil B. “Race-Based” Research…

  • How Culture and Science Make Race “Genetic”: Motives and Strategies for Discrete Categorization of the Continuous and Heterogeneous Literature and Medicine Volume 26, Number 1 (Spring 2007) pages 240–268 DOI: 10.1353/lm.2008.0000 Celeste Condit, Distinguished Research Professor University of Georgia Scientists, medical personnel, and others have recently re-asserted the equivalence of human genetic variation and social…

  • Personalized pharmacogenomics aims to use individual genotypes to direct medical treatment. Unfortunately, the loci relevant for the pharmacokinetics and especially the pharmacodynamics of most drugs are still unknown.